Journal of Neuro-Oncology

Papers
(The H4-Index of Journal of Neuro-Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas65
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence62
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma51
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma45
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab43
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases41
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection41
Factors influencing timely diagnosis in neurolymphomatosis39
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery38
Comment on: “Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma”38
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases37
Thalamic involvement in glioblastoma is associated with lower risk of seizures: a retrospective cohort study37
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis36
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp7036
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population35
Oncological value of MRI in brain metastasis: exploring the potential of combining post-contrast T1 TSE (SPACE) and T1 GRE (MPRAGE) for stereotactic radiosurgery planning and surveillance33
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease33
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale33
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma33
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases32
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu30
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas30
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival29
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study28
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy28
Update of NK cell therapy in pediatric brain tumors28
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study28
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review27
Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients27
0.11912202835083